Wockhardt Limited — Others, 16-07-2025: Shareholders meeting

Wockhardt Limited has announced its 26th Annual General Meeting on August 8, 2025, to adopt the audited annual financial results for FY2024-25. The company posted a consolidated total income of ₹ 3,074 Crore and an EBITDA of ₹ 455 Crore. Shareholders will consider a capital raise up to ₹ 2,000 Crore and executive pay adjustments. Operational highlights include strong growth in UK, ROW, and India, plus significant progress on novel antibiotics like Zaynich and Miqnaf, which gained key regulatory approvals and showed compelling clinical data.